Chemours Posts 3Q EPS of $1.29
CC sits 26% above its 52-week low of $10.44 on elevated volume (1.9× avg).
Summary
Chemours reported third-quarter EPS of $1.29, alongside sales of $1.5B and net income of $196M, the first hard earnings number since the Q2 10-Q showed a $274M net loss and negative stockholders' equity of $48M. Adjusted EPS came in at 21c. The headline carries no guidance or year-over-year comparison, so the quality of the beat or miss can't be judged from this alone. Context matters: the balance sheet is stretched and environmental and litigation reserves stood at $1.45 billion combined as of the last 10-Q, so any earnings recovery is being weighed against that liability load. The stock trades near $13 with a market cap under $2 billion, so a single quarter's print can move it sharply. Full segment detail — TiO2 pricing, AI data center cooling traction — and any guidance update will determine whether this holds.
At the time of this announcement, CC was trading at $13.16 on NYSE in the Manufacturing sector, with a market capitalization of approximately $2B. The 52-week trading range was $10.44 to $28.67. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.